Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Nov 30, 2021

SELL
$3.76 - $5.14 $1.88 Million - $2.56 Million
-498,688 Closed
0 $0
Q1 2021

Nov 30, 2021

BUY
$4.81 - $8.74 $687,685 - $1.25 Million
142,970 Added 40.19%
498,688 $2.52 Million
Q4 2020

Nov 30, 2021

BUY
$5.03 - $6.31 $18,827 - $23,618
3,743 Added 1.06%
355,718 $1.87 Million
Q3 2020

Nov 29, 2021

BUY
$4.67 - $11.0 $1.64 Million - $3.87 Million
351,975 New
351,975 $1.84 Million

Others Institutions Holding MNOV

About MEDICINOVA INC


  • Ticker MNOV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 49,046,200
  • Market Cap $106M
  • Description
  • MediciNova, Inc., a biopharmaceutical company, focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States. The company is developing MN-166 (ibudilast), an oral anti-inflammatory and neuroprotective agent for treating neurological disorders, such as primary and ...
More about MNOV
Track This Portfolio

Track Morgan Jess S & CO Inc Portfolio

Follow Morgan Jess S & CO Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Jess S & CO Inc, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Jess S & CO Inc with notifications on news.